NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Lodewijk de Vink has joined the firm as a Senior Advisor.
"Lodewijk is a proven industry leader with a wealth of management and advisory experience,” said Alan Schwartz, Executive Chairman of Guggenheim Partners and Chairman of Guggenheim Securities. “His unique perspective and deep industry expertise will be highly additive to our healthcare franchise.”
Mr. de Vink added, “I am very honored to be playing an advisory role in Guggenheim’s healthcare endeavors.”
Mr. de Vink is an internationally known leader in the pharmaceutical industry, retiring from Warner Lambert in June 2000 after spending 12 years with the company and last serving as Chairman, President, and CEO. Prior to Warner Lambert, he spent 20 years with Schering-Plough, rising to President of Schering International. Post-retirement, Mr. de Vink served as a Founding Partner and Senior Advisor for Blackstone Health Care Partners.
Mr. de Vink graduated from Nijenrode, The Netherlands School of Business. He also holds a B.B.A. from Washburn University and an MBA from American University.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $240 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
*Assets under management are as of 03.31.2016 and include consulting services for clients whose assets are valued at approximately $56bn.